9 insiders reported 34 Form 4 transactions for Akoya Biosciences, Inc. (AKYA) over the past 18 months (most recent 2025-07-10). Recent activity: Raffin Thomas A. (Director) Sell 234,592 shares, Raffin Thomas A. (Director) Sell 1.7M shares, Raffin Thomas A. (Director) Sell 15.9M shares, Ramachandran Niro Ph.D (Chief Business Officer) Buy 62,566 shares, Ramachandran Niro Ph.D (Chief Business Officer) Sell 42,148 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-10 | Raffin Thomas A. | Director | Sell | 234,592 | $0 |
| 2025-07-10 | Raffin Thomas A. | Director | Sell | 1.7M | $0 |
| 2025-07-10 | Raffin Thomas A. | Director | Sell | 15.9M | $0 |
| 2025-07-10 | Ramachandran Niro Ph.D | Chief Business Officer | Buy | 62,566 | $0 |
| 2025-07-10 | Ramachandran Niro Ph.D | Chief Business Officer | Sell | 42,148 | $0 |
| 2025-07-10 | Ramachandran Niro Ph.D | Chief Business Officer | Sell | 151,930 | $0 |
| 2025-07-10 | Ramachandran Niro Ph.D | Chief Business Officer | Sell | 130,625 | $0 |
| 2025-07-10 | Winkler Matthew | Director | Sell | 984,513 | $0 |
| 2025-07-10 | Mendel Scott | Director | Sell | 28,500 | $0 |
| 2025-07-10 | McKelligon Brian | President and CEO | Buy | 393,338 | $0 |
| 2025-07-10 | McKelligon Brian | President and CEO | Buy | 331,090 | $0 |
| 2025-07-10 | McKelligon Brian | President and CEO | Sell | 196,866 | $0 |
| 2025-07-10 | McKelligon Brian | President and CEO | Sell | 947,688 | $0 |
| 2025-07-10 | BAMFORD PASCAL | Chief Clinical Officer | Sell | 9,488 | $0 |
| 2025-07-10 | BAMFORD PASCAL | Chief Clinical Officer | Sell | 196,250 | $0 |
| 2025-07-10 | Ek John Frederick | CFO | Sell | 54,452 | $0 |
| 2025-07-10 | Ek John Frederick | CFO | Sell | 193,750 | $0 |
| 2025-07-10 | Ek John Frederick | CFO | Sell | 20,000 | $0 |
| 2025-07-10 | LAI GOLDMAN MYLA | Director | Sell | 20,000 | $0 |
| 2025-07-10 | Kamocsay Jennifer | Chief Legal Officer | Sell | 16,772 | $0 |
| 2025-07-10 | Kamocsay Jennifer | Chief Legal Officer | Sell | 162,500 | $0 |
| 2025-06-02 | BAMFORD PASCAL | Chief Clinical Officer | Sell | 670 | $838 |
| 2025-04-03 | Ek John Frederick | CFO | Sell | 16,432 | $22,183 |
| 2025-03-25 | McKelligon Brian | President and CEO | Sell | 7,550 | $12,835 |
| 2025-03-25 | Ramachandran Niro Ph.D | Chief Business Officer | Sell | 2,310 | $3,927 |
Source: SEC Form 4 filings · as of 2025-07-10
